Product NDC: | 0409-2051 |
Proprietary Name: | Ketamine Hydrochloride |
Non Proprietary Name: | KETAMINE HYDROCHLORIDE |
Active Ingredient(s): | 100 mg/mL & nbsp; KETAMINE HYDROCHLORIDE |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION, CONCENTRATE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-2051 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074549 |
Marketing Category: | ANDA |
Start Marketing Date: | 19960627 |
Package NDC: | 0409-2051-05 |
Package Description: | 10 VIAL, MULTI-DOSE in 1 BOX (0409-2051-05) > 5 mL in 1 VIAL, MULTI-DOSE |
NDC Code | 0409-2051-05 |
Proprietary Name | Ketamine Hydrochloride |
Package Description | 10 VIAL, MULTI-DOSE in 1 BOX (0409-2051-05) > 5 mL in 1 VIAL, MULTI-DOSE |
Product NDC | 0409-2051 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | KETAMINE HYDROCHLORIDE |
Dosage Form Name | INJECTION, SOLUTION, CONCENTRATE |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 19960627 |
Marketing Category Name | ANDA |
Labeler Name | Hospira, Inc. |
Substance Name | KETAMINE HYDROCHLORIDE |
Strength Number | 100 |
Strength Unit | mg/mL |
Pharmaceutical Classes | General Anesthesia [PE],General Anesthetic [EPC] |